PubRank

A Zink

Author PubWeight™ 67.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002 6.12
2 European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2011 2.74
3 Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006 2.72
4 Ankylosing spondylitis: an overview. Ann Rheum Dis 2002 2.71
5 Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 2011 2.67
6 Positioning of total knee arthroplasty with and without navigation support. A prospective, randomised study. J Bone Joint Surg Br 2003 2.61
7 Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 2008 2.55
8 Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum 2003 2.20
9 Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM 1996 1.93
10 Molecular evidence for tuberculosis in an ancient Egyptian mummy. Lancet 1997 1.91
11 Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology (Oxford) 2005 1.82
12 Importance of psychological well being and disease activity in termination of an initial DMARD therapy. J Rheumatol 1997 1.77
13 Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum 2008 1.66
14 Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis 2004 1.53
15 HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group. J Rheumatol 2000 1.49
16 Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2008 1.39
17 Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide. Ann Rheum Dis 2009 1.30
18 Loss of physical independence in rheumatoid arthritis: interview data from a representative sample of patients in rheumatologic care. Arthritis Care Res 2000 1.29
19 [Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist]. Z Rheumatol 2010 1.28
20 [Burden of illness. First routine report on socio-medical consequences of inflammatory rheumatic disease in Germany]. Z Rheumatol 2008 1.26
21 Ancient Egyptian prosthesis of the big toe. Lancet 2001 1.18
22 Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol 2000 1.14
23 Detection of leprosy in ancient human skeletal remains by molecular identification of Mycobacterium leprae. Am J Clin Pathol 2000 1.11
24 Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology (Oxford) 2008 1.10
25 Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial. Arthritis Rheum 1996 1.09
26 Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2004 1.07
27 The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database. Clin Exp Rheumatol 2009 1.02
28 Anthropological and palaeopathological analysis of the human remains from three "Tombs of the Nobles" of the necropolis of Thebes-west, upper Egypt. Anthropol Anz 2000 0.98
29 Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 2002 0.98
30 [Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany]. Z Rheumatol 2003 0.96
31 [Macroscopic and endoscopic examinations of the head and neck region in ancient Egyptian mummies]. HNO 2004 0.95
32 PCR-induced sequence alterations hamper the typing of prehistoric bone samples for diagnostic achondroplasia mutations. Mol Biol Evol 2004 0.94
33 Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980-88. J Rheumatol 1998 0.93
34 Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis. Ann Rheum Dis 2004 0.91
35 Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 2008 0.90
36 Accidental poisoning in childhood from the epidemiological viewpoint-An analysis of 323 cases of poisoning in children under eight years of age-. Vet Hum Toxicol 1981 0.90
37 Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement. Ann Rheum Dis 2004 0.90
38 [Routine report on the medical rehabilitation of patients with musculoskeletal diseases]. Z Rheumatol 2005 0.89
39 Molecular evidence for different stages of tuberculosis in ancient bone samples from Hungary. Am J Phys Anthropol 2000 0.87
40 [Prophylaxis and treatment of osteoporosis in patients with rheumatoid arthritis (ORA study)]. Z Rheumatol 2011 0.86
41 [Comorbidity in rheumatoid arthritis of early onset. Effects on outcome parameters]. Z Rheumatol 2006 0.86
42 [Paleopathology of ancient Egyptian mummies and skeletons. Investigations on the occurrence and frequency of specific diseases during various time periods in the necropolis of Thebes-West]. Pathologe 2002 0.85
43 Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Rheumatology (Oxford) 2006 0.84
44 Major role of dihydropyridine-sensitive Ca2+ channels in Ca(2+)-induced calcitonin secretion. Am J Physiol 1993 0.84
45 [Epidemiology of primary Sjörgren's syndrome]. Z Rheumatol 2010 0.84
46 [Epidemiological and socio-psychological aspects of accidents in childhood (author's transl)]. Monatsschr Kinderheilkd 1980 0.83
47 Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis. Ann Rheum Dis 2008 0.82
48 [Transition clinic--it is not always a simple segue in rheumatology for adults]. Z Rheumatol 2005 0.81
49 [Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists]. Z Rheumatol 2011 0.81
50 Down-regulation of calcitonin receptors in T47D cells by internalization of calcitonin-receptor complexes. Mol Cell Endocrinol 1988 0.80
51 Kinematic analysis and position/force control of the Anthrobot dextrous hand. IEEE Trans Syst Man Cybern B Cybern 1997 0.79
52 Inhibition of Ca(2+)-induced calcitonin secretion by somatostatin: roles of voltage dependent Ca2+ channels and G-proteins. Cell Signal 1992 0.78
53 [Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis]. Z Rheumatol 2013 0.78
54 [Help status and help prospects of severely handicapped patients with rheumatoid arthritis]. Z Rheumatol 2001 0.78
55 [Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany]. Z Rheumatol 2005 0.77
56 Measurement of free cytosolic calcium in single cells: method and application. Methods Find Exp Clin Pharmacol 1992 0.77
57 Halophilic bacteria are colonizing the exhibition areas of the Capuchin Catacombs in Palermo, Italy. Extremophiles 2014 0.77
58 Clinical features of multiple endocrine neoplasia type 1 and type 2. Horm Res 1992 0.77
59 [Outcome measurement in musculoskeletal diseases: recommendation for a core set of scales for use in rehabilitation]. Z Rheumatol 2001 0.76
60 [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany]. Z Rheumatol 2004 0.76
61 [Biomarkers in rheumatology. Biomarkers and imaging for the diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the ArthroMark network funded by the Federal Ministry of Education and Research]. Z Rheumatol 2012 0.76
62 [Methodologic aspects of public health economy]. Z Rheumatol 2004 0.75
63 [Out-of-pocket medical spending for care in patients with recent onset rheumatoid arthritis]. Z Rheumatol 2004 0.75
64 [Epidemiology of rheumatic diseases in the German Federal Republic-- current state and perspectives]. Z Rheumatol 1992 0.75
65 [Primary human demodicosis. A disease sui generis]. Hautarzt 2015 0.75
66 Regulation of calcitonin secretion in vitro. Horm Metab Res 1993 0.75
67 Long-term exposure to SMS 201-995 inhibits proliferation and calcitonin release in neoplastic C-cells. Horm Metab Res 1993 0.75
68 [Accidental poisonings in children under eight years of age: epidemiology--social risks (author's transl)]. Przegl Lek 1981 0.75
69 An open distributed medical image and signal data server network with World Wide Web front-end. Stud Health Technol Inform 1997 0.75
70 ["Don't smoke"--a confirmed factor in the primary prevention of rheumatoid arthritis]. Z Rheumatol 2006 0.75
71 [Epidemiology of accidents in childhood]. Monatsschr Kinderheilkd 1984 0.75
72 [Morbidity and mortality in systemic rheumatoid diseases: how did they change?]. Z Rheumatol 2011 0.75
73 [Preface]. Z Rheumatol 2002 0.75
74 [Goals and methods of clinical studies]. Z Rheumatol 2000 0.75
75 [Life and suffering 5,000 years ago. Paleopathologic findings in the "man from the ice"]. MMW Fortschr Med 1999 0.75
76 [Basic treatment of early rheumatoid arthritis. Abstaining from rheumatological care and preferring alternative medicine increase the risk of undertreatment]. Z Rheumatol 2007 0.75
77 [Presentation of the Center of Competence in Berlin]. Z Rheumatol 2002 0.75
78 Regulation of calcitonin secretion and calcitonin gene expression. Recent Results Cancer Res 1992 0.75
79 Action of calcitonin gene-related peptide at the calcitonin receptor of the T47D cell line. Horm Metab Res 1987 0.75
80 Childhood poisoning in a paediatric hospital: the Luebeck experience. Hum Toxicol 1983 0.75
81 [The importance of patient perspective in drug surveillance systems]. Z Rheumatol 2010 0.75
82 A shortened docetaxel desensitization protocol for use in special cases. J Eur Acad Dermatol Venereol 2011 0.75
83 [The role of somatostatin on the cellular level]. Med Klin (Munich) 1993 0.75
84 [New findings regarding an "ancient illness"]. MMW Fortschr Med 2000 0.75
85 Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma. J Endocrinol Invest 1992 0.75
86 [Results of early rehabilitation using various knee prosthesis models]. Rehabilitation (Stuttg) 1996 0.75